SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk (SNDK) continues to experience historic, parabolic price appreciation driven by severe enterprise NAND flash shortages and aggressive institutional re-rating of the memory sector. The community remains deeply polarized, with bulls pointing to multi-year capacity constraints and essential AI infrastructure demand, while skeptics warn of extreme technical overextension and potential bubble risks.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is seeing a strong surge in investor interest driven by momentum in its weight-loss peptide pipeline and positive analyst revisions, fueling active community discussions regarding a potential short squeeze. Traders are closely monitoring key technical levels and institutional flows as the company moves to capitalize on expanding telehealth demand.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant attention as investors anticipate the release of Phase 3 VELA study data, with the community actively debating potential acquisition outcomes and the asset's clinical superiority. Discussion is dominated by the strategic timing of this data release alongside key investor conferences, fueling speculation regarding a significant valuation rerating and heightened M&A activity.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is rallying as investors react to reports of a domestic chip manufacturing partnership with Apple, a move that reinforces optimism in the company's ongoing foundry transformation. The stock is seeing significant momentum and high volume as the community actively debates whether this catalyst justifies the current valuation or represents a speculative pump.

FreeCast, Inc. operates an online video streaming platform. Its cloud entertainment platform comprises the largest aggregated library of free and pay-per-view video-on-demand, streaming channels, live events, radio stations, music videos and online games. The company was founded by William A. Mobley, Jr. on June 21, 2011 and is headquartered in Orlando, FL.

Freecast Inc - Ordinary Shares - Class A

Freecast Inc

Freecast Inc is experiencing a significant surge driven by a strategic reseller agreement with SpaceX's Starlink, which has ignited intense interest in the stock as a potential squeeze candidate. The community remains highly polarized, with bulls tracking momentum indicators and institutional partnerships, while skeptics point to the company's financial history and the potential for volatility following such a rapid climb.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is trending due to strong market interest in its role as a key player in AI infrastructure, specifically regarding memory and high-performance computing demand. The community is actively discussing its potential for a significant re-rating, highlighting its partnerships with major hardware vendors and the scalability of its integrated memory solutions.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is currently drawing significant community attention as it navigates a complex intersection of geopolitical headwinds and institutional support, specifically surrounding China's export control list and the company's critical role as a U.S. rare earth supplier. Investors are actively debating the stock's consolidation patterns near technical resistance levels, while closely monitoring how the firm's domestic magnet production and defense-linked government backing will offset macro-level uncertainty.

The Campbell's Co. engages in the business of manufacturing and marketing food and beverage products. It operates under the Meals and Beverages, and Snacks segments. The Meals and Beverages segment includes soup, meals, and beverage products in retail and foodservice. The Snacks segment offers cookies, crackers, bakery, and frozen products. The company was founded by Joseph Campbell and Abraham Anderson in 1869 and is headquartered in Camden, NJ.

Campbells Co (The)

Campbell Soup Co.

Campbell Soup Co. is trending as it faces removal from the S&P 500 in favor of tech-focused equities, prompting intense debate among retail investors about whether the stock is a deep-value defensive opportunity or a structural yield trap. The community is actively discussing the stock's significant dividend yield, institutional short interest, and whether a potential takeover or strategic divestiture could catalyze a turnaround from its recent multi-year lows.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors await a federal court decision on whether to remand the company's lawsuit against partner Nippon Shinyaku back to state court, a move seen as critical to securing independent distribution rights ahead of the expected August PDUFA date. Community focus remains locked on the potential for Deramiocel's approval to transform the standard of care for Duchenne Muscular Dystrophy, with many speculating that resolving the legal overhang will clear the path for the stock's next major leg up.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending as investors react to the company's major $1.6 billion federal funding package and new facility announcements, which have sparked bullish sentiment regarding its role in the domestic critical minerals supply chain. Community members are actively debating the stock's long-term potential as a government-backed rare earth leader versus concerns over litigation and the impact of share dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$QXL 
 
+5%, ~$68M market cap, testing 52-week highs. 
 
A low-profile Nasdaq quantum name that is still under the radar. 
 
Formerly Viewbix, the company completed its transformation after acquiring Quantum X Labs in 2026 and rebranded as $QXL. 
 
Core thesis has fully shifted into a full-stack quantum platform: 
 
• Quantum computing 
• AI-driven quantum error correction 
• Quantum sensing &amp; navigation 
• Atomic clocks 
• Biomedical &amp; nuclear simulation 
• Cybersecurity applications 
 
Key developments: 
• Launch of 50+ physical qubit neutral-atom platform 
• Roadmap targeting thousands of qubits by 2027 
• AI-based quantum error correction integrating Google Quantum datasets 
• Patent filing in atomic clock tech 
• Expanding sensing and commercial applications 
 
Core bottleneck remains quantum error correction, widely seen as the key scaling challenge in the industry. 
 
Q1 revenue ~$353K, but this is positioning as a platform play, not a single-product company.

Haim

StockTwits Web

Quantum X Labs Inc.

 
 
+5%, ~$68M market cap, testing 52-week highs. 
 
A low-profile Nasdaq quantum name that is still under the radar. 
 
Formerly Viewbix, the company completed its transformation after acquiring Quantum X Labs in 2026 and rebranded as 

. 
 
Core thesis has fully shifted into a full-stack quantum platform: 
 
• Quantum computing 
• AI-driven quantum error correction 
• Quantum sensing & navigation 
• Atomic clocks 
• Biomedical & nuclear simulation 
• Cybersecurity applications 
 
Key developments: 
• Launch of 50+ physical qubit neutral-atom platform 
• Roadmap targeting thousands of qubits by 2027 
• AI-based quantum error correction integrating Google Quantum datasets 
• Patent filing in atomic clock tech 
• Expanding sensing and commercial applications 
 
Core bottleneck remains quantum error correction, widely seen as the key scaling challenge in the industry. 
 
Q1 revenue ~$353K, but this is positioning as a platform play, not a single-product company.